Mount Sinai School of Medicine researchers studied the effects of the particular kind of red wine on Alzheimer's disease using a mouse model.
Giulio Maria Pasinetti and Jun Wang said it was the first study of its kind.
The authors of the study said, "This study supports epidemiological evidence indicating that moderate wine consumption, within the range recommended by the FDA dietary guidelines of one drink per day for women and two for men, may help reduce the relative risk for AD clinical dementia."
The researchers used 11-month-old transgenic mice with AD-type â-amyloid (Aâ) neuropathology, to look for improvements in cognitive loss and AD-type neuropathology after red wine consumption.
Interestingly, they found that Cabernet Sauvignon significantly lowered AD-type deterioration of spatial memory function as well as Aâ neuropathology in mice when compared with control mice.
Giulio Maria Pasinetti, Director of the Neuroinflammation Research Center at Mount Sinai School of Medicine and lead author of the study said that the study would provide hope to countless number of people suffering from Alzheimer's.
Pasinetti was quoted by Asia News International as saying: "These findings give researchers and millions of families a glimpse of light at the end of the long dark tunnel for future prevention of this disease."
The study is to be presented at the "Society for Neuroscience Meeting" in Atlanta, Georgia, from October 14-18, 2006 and it will be published in the November 2006 issue of The FASEB Journal.
